Open NowResearch2026

Cochrane Funding Program 2026

National Health and Medical Research Council (NHMRC) · Australia

The Cochrane Funding Program 2026 provides Australian Government funding to support Cochrane activities in Australia over four years. It aims to support Australian Cochrane review production and evidence synthesis to inform healthcare decision making.

Funding

Up to $6.5M

Deadline

1 May 2026

Duration

up to 4 years

Location

Australia

Who Can Apply

- Only NHMRC approved Administering Institutions may apply - Applicants must meet all requirements in the Cochrane Funding 2026 Grant Guidelines - The grant is only available to Cochrane Australia
Applications will only be accepted from NHMRC approved Administering Institutions. Applications must satisfy all the requirements set out in the Cochrane Funding 2026 Grant Guidelines. This grant is only available to Cochrane Australia.

What's Funded

Production of Cochrane reviews, evidence synthesis, and related activities that support evidence-based healthcare decision making and translation of research into public policy, health systems and clinical practice.

Expected Outcomes

Australian Cochrane review production and evidence synthesis outputs delivered over up to four years to support healthcare decision making and high-value evidence-based practice.

Key Information

Applicant Types

universitynon_profit

Stage

established

Funding Purposes

researchcommunityother

Keywords

medical researchCochraneevidence synthesissystematic reviewshealthcare decision makingevidence-based practiceNHMRCclinical healthcare

Frequently Asked Questions

What is the Cochrane Funding Program 2026?

The Cochrane Funding Program 2026 is a research grant offered by National Health and Medical Research Council (NHMRC) in Australia, providing Up to $6.5M in funding. The Cochrane Funding Program 2026 provides Australian Government funding to support Cochrane activities in Australia over four years. It aims to support Australian Cochrane review production and evidence synthesis to inform healthcare decision making.

How much funding does the Cochrane Funding Program 2026 provide?

The Cochrane Funding Program 2026 provides Up to $6.5M in funding. The typical project duration is up to 4 years.

Who is eligible for the Cochrane Funding Program 2026?

- Only NHMRC approved Administering Institutions may apply - Applicants must meet all requirements in the Cochrane Funding 2026 Grant Guidelines - The grant is only available to Cochrane Australia

When does the Cochrane Funding Program 2026 close?

Applications close on 1 May 2026.

What activities are funded?

Production of Cochrane reviews, evidence synthesis, and related activities that support evidence-based healthcare decision making and translation of research into public policy, health systems and clinical practice.

How do I apply for the Cochrane Funding Program 2026?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.